Skip to content

A series of studies on the neuromodulation of working memory deficits in schizophrenia

A series of studies on the neuromodulation of working memory deficits in schizophrenia

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057286
Enrollment
Unknown
Registered
2022-03-07
Start date
2022-03-07
Completion date
Unknown
Last updated
2023-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia

Interventions

Healthy control group:None
TMS stimulation group:Transcranial magnetic stimulation treatment
Pseudo TMS stimulation group:Pseudo-transcranial magnetic stimulation treatment

Sponsors

Beijing Anding Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Chinese Han nationality, right-handed, 18-45 years, junior high school education or above, normal intelligence test (IQ >= 75); 2. The patient was interviewed by a clinician at or above the attending physician level and determined to meet the DSM-IV diagnostic criteria for schizophrenia; 3. The patient's symptoms have been stable for more than 2 weeks after treatment with stable dose drugs; 4. No history of major physical diseases, craniocerebral trauma, no history of epilepsy or family history, no MRI contraindications; 5. Patient Health Questionnaire-9 (PHQ-9) score >= 10; 6. The subject is willing to participate in the study, and the subject and his legal guardian jointly sign the informed consent; 7. Healthy volunteers have no history of alcohol and drug abuse; 8. Healthy volunteers had no family history of neurological diseases (except cerebrovascular accidents); 9. The healthy volunteers had no current history of clearly diagnosed neurological and other serious physical disorders.

Exclusion criteria

Exclusion criteria: 1. Patients with nuclear contraindications such as metal implants such as dentures, arterial clips, pacemakers or metal fixators in the body; 2. Claustrophobic and unable to cooperate with the completion of the magnetic test.

Design outcomes

Primary

MeasureTime frame
brain functional connectivity;event-related potentials;positive and negative syndrome scale;

Secondary

MeasureTime frame
MATRICS consensus cognitive battery;Calgary depression scale for schizophrenia;

Countries

China

Contacts

Public ContactLi Jun

Beijing Anding Hospital

lijundp@bnu.edu.cn+86 13691008200

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026